Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis

A Kumar, S Roy, S Tripathi… - Journal of Biomolecular …, 2016 - Taylor & Francis
Beta-site APP cleaving enzyme1 (BACE1) catalyzes the rate determining step in the
generation of Aβ peptide and is widely considered as a potential therapeutic drug target for …

Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification

MA Islam, TS Pillay - Journal of Molecular Graphics and Modelling, 2015 - Elsevier
Pharmacoinformatics approaches are widely used in the field of drug discovery as it saves
time, investment and animal sacrifice. In the present study, pharmacore-based virtual …

[PDF][PDF] Squaryl Molecular Metaphors Application to Rational Drug Design and Imaging Agents

SL Kitson - Journal of Diagnostic Imaging in Therapy, 2017 - pdfs.semanticscholar.org
Molecular Metaphors is the application of squaryl building blocks towards creative functional
group chemistry to produce lead compounds and imaging agents. This strategy is applied to …

Accurate prediction of inhibitor binding to HIV-1 protease using CANDOCK

Z Falls, J Fine, G Chopra, R Samudrala - Frontiers in Chemistry, 2022 - frontiersin.org
The human immunodeficiency virus 1 (HIV-1) protease is an important target for treating HIV
infection. Our goal was to benchmark a novel molecular docking protocol and determine its …

Expedient screening for HIV-1 protease inhibitors using a simplified immunochromatographic assay

K Kitidee, W Khamaikawin, W Thongkum… - … of Chromatography B, 2016 - Elsevier
ABSTRACT A colloidal gold-based immunochromatographic (IC) strip test was developed
and validated for the detection of HIV-1 protease (HIV-PR) activity and inhibitory effect of HIV …

Discovery of Novel Multi-target Inhibitor of angiotensin type 1 receptor and neprilysin inhibitors from Traditional Chinese Medicine

X Huo, L Qiao, Y Chen, X Chen, Y He, Y Zhang - Scientific Reports, 2019 - nature.com
Angiotensin II type-1 receptor–neprilysin inhibitor (ARNi) is consisted of Angiotensin II type-1
receptor (AT1) antagonist and neprilysin (NEP) inhibitor, which could simultaneously …

Pharmacophore-driven identification of N-methyl-D-receptor antagonists as potent neuroprotective agents validated using in vivo studies

M Sharma, A Mittal, A Singh… - Biology Methods and …, 2020 - academic.oup.com
Abstract Alzheimer's disease (AD), apparently the most widespread reason behind
dementia, is delineated by a continuous cognitive weakening in the aged. During its …

Pharmacophore and molecular docking based identification of novel structurally diverse PDE-5 inhibitors

S Paliwal, A Mittal, M Sharma, A Pandey… - Medicinal Chemistry …, 2015 - Springer
In view that PDE5 is a potential target for the design of antihypertensive drugs a
pharmacophore and molecular docking based virtual screening protocol was implemented …

An overview of antiretroviral agents for treating HIV infection in paediatric population

R Melo, A Lemos, AJ Preto… - Current Medicinal …, 2020 - ingentaconnect.com
Paediatric Acquired ImmunoDeficiency Syndrome (AIDS) is a life-threatening and infectious
disease in which the Human Immunodeficiency Virus (HIV) is mainly transmitted through …

Chemical Feature‐Based Molecular Modeling of Urotensin‐II Receptor Antagonists: Generation of Predictive Pharmacophore Model for Early Drug Discovery

A Pandey, SK Paliwal, SK Paliwal - Journal of Chemistry, 2014 - Wiley Online Library
For a series of 35 piperazino‐phthalimide and piperazino‐isoindolinone based urotensin‐II
receptor (UT) antagonists, a thoroughly validated 3D pharmacophore model has been …